"This is a very different
population than they're used to serving, it's a very different bidding process,
a very different regulatory environment. They would have to learn an awful lot
about that business if they were starting a de novo program, or they would have
to go out and acquire somebody."
— Joseph Paduda, principal of Health
Strategy Associates, LLC, explains to Health
Plan Weekly why more health insurers don't follow Centene Corp.'s
footsteps and enter the correctional care market.
No comments:
Post a Comment